Clinical Trial Update: Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effect of inhalation propellants HFA-152a and HFA-134a on mucociliary clearance in healthy participants; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• HFA-134a (1,1,1,2-tetrafluoroethane)
• HFA-152a (1,1-difluoroethane)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2026-04-14